Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial Article

Industry Collaboration

cited authors

  • Eisen, Alon; Giugliano, Robert P.; Ruff, Christian T.; Nordio, Francesco; Gogia, Harinder S.; Awasty, Vivek R.; Henderson, David A.; Mercuri, Michele F.; Rutman, Howard; Antman, Elliott M.; Braunwald, Eugene

Publication Date

  • February 1, 2016

webpage

published in

category

start page

  • 144

end page

  • 151

volume

  • 172